Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Emerging role of exosomes in cancer therapy: progress and challenges
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 10
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Microbiome and pancreatic cancer: time to think about chemotherapy
Juliana de Castilhos, Katharina Tillmanns, J. A. BLESSING, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review
Zahra Zahedifard, Shirin Mahmoodi, Abdolmajid Ghasemian
Biotechnology and Applied Biochemistry (2025)
Closed Access | Times Cited: 1
Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses
Ashok Kumar Jangid, Kyung Mu Noh, Sung Jun Kim, et al.
Carbohydrate Polymers (2024) Vol. 340, pp. 122311-122311
Closed Access | Times Cited: 5
The role of microbiome in CAR-T cell therapy
Reham Abdel‐Wahab, Travis Kerr, Daniel J. McGrail, et al.
International review of cell and molecular biology (2025)
Closed Access
Unveiling the orchestration of T-cell dynamics: A comprehensive examination of their crucial role in revolutionizing immunotherapy for pancreatic and colon cancers
Sridevi Mardham, Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 199-232
Closed Access
Bacterial metabolites: Effects on the development of breast cancer and therapeutic efficacy (Review)
Yan Guo, Wenyan Dong, Dezheng Sun, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-9
Open Access
Microbiome and Human Cancer: Descriptive Literature Review
Diana N Arutyunyan, В. Д. Петрова, С. А. Терехова, et al.
Russian Journal of Oncology (2025)
Open Access
Streptococcus anginosus promotes gastric cancer progression via GSDME-mediated pyroptosis pathway: Molecular mechanisms of action of GSDME, cleaved caspase-3, and NLRP3 proteins
Zeshen Wang, Ruishu Mou, Shiyang Jin, et al.
International Journal of Biological Macromolecules (2025), pp. 142341-142341
Closed Access
Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitors.
C. Bonnefin, S. Schneider, E. Gérard, et al.
European Journal of Cancer (2025), pp. 115223-115223
Closed Access
Living, Heat-Killed Limosilactobacillus mucosae and Its Cell-Free Supernatant Differentially Regulate Colonic Serotonin Receptors and Immune Response in Experimental Colitis
Zhiyuan Sun, Siqi Huang, Xing‐Gang Yan, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 468-468
Open Access | Times Cited: 3
Gut microbes as medical signature for the effectiveness of immunotherapy in patients with advanced non‐small cell lung cancer
Adane Adugna, Yalew Muche, Mohammed Jemal, et al.
Aging Medicine (2024) Vol. 7, Iss. 1, pp. 121-130
Open Access | Times Cited: 1
Integrating AI-driven Wearable Technology in Oncology Decision Making: A Narrative Review
Meghna Birla, Rajan, Prabhat Gautam Roy, et al.
Oncology (2024), pp. 1-13
Open Access | Times Cited: 1
Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
Jeanette A.M. Maier, Sara Castiglioni, Alessandra Petrelli, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Unraveling Shared and Unique Genetic Causal Relationship Between Gut Microbiota and Four Types of Uterine-Related Diseases: Bidirectional Mendelian Inheritance Approaches to Dissect the "Gut-Uterus Axis"
Liming Li, Shengmei Yang, Ruming Li, et al.
Annals of Epidemiology (2024) Vol. 100, pp. 16-26
Closed Access | Times Cited: 1
EGFR bypass activation mediates acquired resistance to regorafenib in hepatocellular carcinoma
Lili Hu, Weiwei Shi, Kua Liu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Potential of natural products and gut microbiome in tumor immunotherapy
Luchang Cao, Xinmiao Wang, Xinyi Ma, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGFβ2 and EMT
Lingkai Kong, Qinyu He, Ding Ma, et al.
FEBS Open Bio (2024) Vol. 14, Iss. 5, pp. 831-842
Open Access
The Potential Role of Intestinal Stem Cells and Microbiota for the Treatment of Colorectal Cancer
Babak Arjmand, Sepideh Alavi-Moghadam, Zahra Faraji, et al.
Advances in experimental medicine and biology (2024), pp. 115-128
Closed Access
Intratumoral microbiota: an emerging force in diagnosing and treating hepatocellular carcinoma
Huanxiang Liu, Jiahao Zhang, Yuan James Rao, et al.
Medical Oncology (2024) Vol. 41, Iss. 12
Closed Access
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy
Francesco Vitiello, Caterina Vivaldi, Margherita Rimini, et al.
(2024)
Closed Access
Page 1

Scroll to top